{
  "report_rows": [
    {
      "kpi": "Q2 2026 sales",
      "prediction": "BEAT",
      "answer": "pred ~$2.720B vs. cons $2.692B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 adjusted operating EBITDA",
      "prediction": "BEAT",
      "answer": "pred ~$537M vs. cons $530M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$1.14 vs. cons $1.12",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 sales guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$10.5B-$10.8B vs. cons $10.74B (FY2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "FY2026 adjusted operating EBITDA guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$2.05B-$2.15B vs. cons $2.107B (FY2026)",
      "confidence": "HIGH"
    }
  ],
  "day1_residual_pct": 2.8,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 0.9,
  "day5_path": "FADE",
  "day5_rationale": "A modest Q2 EBITDA beat of ~$537M vs. $530M consensus and confirmation that Q2 was the trough should support day 1, but an unchanged FY2026 EBITDA midpoint of ~$2.10B vs. $2.107B consensus implies only ~$995M of H2 EBITDA versus approximately $1.009B embedded before the report, creating modest out-period estimate cuts and a five-day fade.",
  "day5_confidence": "MEDIUM"
}